Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;61(3):297-303.
doi: 10.4111/icu.2020.61.3.297. Epub 2020 Mar 25.

Expression of bladder α1-adrenoceptor subtype after relief of partial bladder outlet obstruction in a rat model

Affiliations

Expression of bladder α1-adrenoceptor subtype after relief of partial bladder outlet obstruction in a rat model

Ji Yong Lee et al. Investig Clin Urol. 2020 May.

Abstract

Purpose: Many patients with benign prostatic hyperplasia require treatment for persistent storage symptoms, even when the obstruction is successfully relieved by surgery. Previous studies identified a characteristic increase in α1D-adrenoceptor levels in the bladder in a bladder outlet obstruction (BOO) model. Here, we investigated the expression of α1-adrenoceptor subtypes in the bladder after relief of partial BOO (pBOO) in a rat model.

Materials and methods: A total of 60 female Sprague-Dawley rats were randomly divided into three groups (sham-operated, pBOO, and pBOO relief groups), and the expression of α1-adrenoceptor subtypes in the urothelium and detrusor muscle tissues was examined by western blot.

Results: The expression of the α1D-adrenoceptor was significantly higher in the urothelium and detrusor muscle tissue of the pBOO and pBOO relief groups than in the corresponding tissue of the sham-operated group. Additionally, the α1A-adrenoceptor was predominant in the sham-operated group but significantly decreased in the urothelium in the pBOO group. No significant differences were found in α1A-adrenoceptor levels in detrusor muscle or whole bladder.

Conclusions: Our results showed that α1D-adrenoceptor levels were consistently increased with pBOO, even after relief, suggesting that the α1D-adrenoceptor might be a cause of persistent storage symptoms after relief of pBOO.

Keywords: Adrenergic alpha-1 receptor antagonists; Lower urinary tract symptoms; Urinary bladder neck obstruction; Urinary bladder, overactive.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. Western blot analysis of α1-adrenoceptor (AR) subtypes in the urothelium. (A) Immunoblot of α1-AR subtypes and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in representative animals. (B) Bar graph showing data for the urothelium from all animals in each group. In the pBOO and the pBOO+R groups, α1A-AR levels were significantly decreased, and α1D-AR levels were significantly increased, relative to the Sham group. α1D-AR levels were significantly decreased in the pBOO+R group relative to the pBOO group. Data represent the mean±standard deviation. *p<0.05 vs. Sham group; p<0.05 vs. pBOO group. BOO, bladder outlet obstruction; pBOO group, rat model of partial BOO; pBOO+R group, rat model of partial BOO relief.
Fig. 2
Fig. 2. Western blot analysis of α1-adrenoceptor (AR) subtypes in the detrusor muscle. (A) Immunoblot of α1-AR subtypes and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in representative animals. (B) Bar graph showing data for the detrusor muscle from all animals in each group. In the pBOO and pBOO+R groups, α1D-AR levels were significantly increased relative to the Sham group, and differences in α1A- and α1B-AR levels were not statistically significant among the three groups. Data represent the mean±standard deviation. *p<0.05 vs. Sham group. BOO, bladder outlet obstruction; pBOO group, rat model of partial BOO; pBOO+R group, rat model of partial BOO relief.
Fig. 3
Fig. 3. Average relative density of α1-adrenoceptor (AR) protein levels in the whole bladder. The bar graph shows data for the urothelium and detrusor muscle tissue represented as the mean±standard deviation. In the pBOO and pBOO+R groups, α1D-AR levels were significantly increased relative to the Sham group and significantly decreased in the pBOO+R group relative to the pBOO group. *p<0.05 vs. Sham group; p<0.05 vs. pBOO group. BOO, bladder outlet obstruction; pBOO group, rat model of partial BOO; pBOO+R group, rat model of partial BOO relief.

References

    1. Yeo JK, Choi H, Bae JH, Kim JH, Yang SO, Oh CY, et al. Korean clinical practice guideline for benign prostatic hyperplasia. Investig Clin Urol. 2016;57:30–44. - PMC - PubMed
    1. Michelotti GA, Price DT, Schwinn DA. Alpha 1-adrenergic receptor regulation: basic science and clinical implications. Pharmacol Ther. 2000;88:281–309. - PubMed
    1. Majima T, Yamamoto T, Funahashi Y, Takai S, Matsukawa Y, Yoshida M, et al. Effect of naftopidil on bladder microcirculation in a rat model of bladder outlet obstruction. Low Urin Tract Symptoms. 2017;9:111–116. - PubMed
    1. Okutsu H, Matsumoto S, Hanai T, Noguchi Y, Fujiyasu N, Ohtake A, et al. Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction. Urology. 2010;75:235–240. - PubMed
    1. Kurizaki Y, Ishizuka O, Imamura T, Ichino M, Ogawa T, Igawa Y, et al. Relation between expression of α(1)-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2011;45:15–19. - PubMed

Publication types

Substances